Audrey Kunin, Chief Product Officer at NovaBay Pharmaceuticals, Inc. (NBY), bought 524,738 shares at $0.48 ($252K) on 2021-12-02, disclosed to the SEC on 2021-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.48 | 262,369 | $126K | 50.0% |
| 2 | $0.48 | 262,369 | $126K | 50.0% |
| Total | $0.48 avg | 524,738 | $252K | 100% |
| Filing → |
| NBY | SELL | 2022-09-16 | $47K | — | Filing → |
| NBY | BUY | 2021-12-07 | $47K | — | Filing → |
| NBY | BUY | 2021-12-03 | $7K | — | Filing → |